A Biontech vaccination recommendation for children under the age of twelve?
Doctors in Germany are hoping for this.
The decision should be made in the next few weeks.
Berlin - The corona incidence in Germany * continues to rise, even in younger age groups.
In view of this development, paediatricians rely on swift vaccinations for those under the age of twelve.
"We hope that in the next few weeks there will be European approval of the Biontech * vaccine for the age group of five to eleven years old, which will then also be adopted in Germany," said the President of the German Society for Pediatric and Adolescent Medicine, Jörg Dötsch, the newspapers of the Funke media group.
Corona in Germany: Before Christmas, vaccination recommendation for under twelve-year-olds?
According to Dötsch, Corona * vaccinations in this age group would be "legally protected" even without the express recommendation of Stiko.
That recommendation could then follow in the following weeks after a closer examination of the data on side effects.
On Wednesday, October 27, the European Medicines Agency (EMA) announced that it would decide before Christmas if possible whether it would recommend vaccinations for children between the ages of five and eleven.
An advisory body to the US FDA advocated emergency approval of the Biontech vaccine for children between the ages of five and eleven this week.
A final FDA decision is expected later this week.
Corona in Germany: soon Biontech vaccination for children under twelve?
In the meantime, Jörg Dötsch made it clear that the paediatricians would follow a corresponding recommendation by Stiko to vaccinate five to eleven year olds.
The physician called immunization of boys and girls at this age sensible.
The aim is to save them from developing corona and to prevent infected children from being isolated and having to stay at home from school.
Because it is known that this absence worsens the mental health of the students.
“The vaccination also protects against this in the end.
That is why it makes sense, ”emphasized Dötsch.
“One in 16,000 children develops a mild cardiac muscle inflammation, but the courses are usually not severe.
The advantages outweigh the breadth. "
By the way: You can read more news from all over the world here.
* Merkur.de is an offer from IPPEN.MEDIA (kof / dpa)
